Amgen Inc. buy Royal Bank of Canada
Start price
26.09.24
/
50%
€284.10
Target price
26.09.25
€324.86
Performance (%)
2.50%
Price
04.10.24
€291.20
Summary
This prediction is currently active. With a performance of 2.50%, the BUY prediction by Royal_Bank_of_Canada for Amgen Inc. is trending in the right direction. This prediction currently runs until 26.09.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Amgen Inc. | 0.761% |
iShares Core DAX® | -1.114% |
iShares Nasdaq 100 | 1.816% |
iShares Nikkei 225® | 2.113% |
iShares S&P 500 | 2.038% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $362.00 price target on the stock.
Ratings data for AMGN provided by MarketBeat